Biguanide Market to Hit USD 18.7 Billion by 2031 Due to Rising Diabetes Rates and Broader Therapeutic Uses
[London, 29 July 2025] – The global biguanide market is projected to grow from USD 10.4 billion in 2024 to USD 18.7 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.4%, according to Clearview Market Insights (CVMI). Metformin continues to lead as the most prescribed oral treatment for type 2 diabetes and is increasingly being used in PCOS, oncology, and geriatric...
0 Comments 0 Shares 4 Views 0 Reviews
Sponsored